Koninklijke Philips NV
AEX:PHIA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
P/B
Price to Book (P/B) ratio compares a company`s market value to its book value. It shows how much investors are paying for each dollar of net assets on the balance sheet.
Price to Book (P/B) ratio compares a company`s market value to its book value. It shows how much investors are paying for each dollar of net assets on the balance sheet.
Valuation Scenarios
If P/B returns to its 3-Year Average (1.5), the stock would be worth €23.29 (0% downside from current price).
| Scenario | P/B Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 1.5 | €23.29 |
0%
|
| 3-Year Average | 1.5 | €23.29 |
0%
|
| 5-Year Average | 1.5 | €23.29 |
0%
|
| Industry Average | 1.5 | €23.29 |
0%
|
| Country Average | 2.2 | €34.87 |
+50%
|
Forward P/B
Today’s price vs future total equity
Peer Comparison
| Market Cap | P/B | P/E | ||||
|---|---|---|---|---|---|---|
| NL |
K
|
Koninklijke Philips NV
AEX:PHIA
|
17.5B EUR | 1.5 | -21.8 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
171.2B USD | 9.6 | 60 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
158.3B USD | 3 | 25.2 | |
| US |
|
Stryker Corp
NYSE:SYK
|
125.3B USD | 5.6 | 38.6 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
106.9B USD | 2.2 | 23.2 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
92B USD | 3.8 | 31.8 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
40B EUR | 2.2 | 18.9 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
48.9B USD | 4.7 | 45.5 | |
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
45.1B USD | 28.1 | 42.6 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
43.3B USD | 1.7 | 24.7 | |
| US |
|
Resmed Inc
NYSE:RMD
|
32B USD | 5.1 | 21.6 |
Market Distribution
| Min | 0 |
| 30th Percentile | 1.4 |
| Median | 2.2 |
| 70th Percentile | 4.4 |
| Max | 589.5 |
Other Multiples
Koninklijke Philips NV
Glance View
Koninklijke Philips NV, more commonly known as Philips, has transformed itself from its origins as a humble light bulb manufacturer in 1891 into a global leader in health technology. The company, headquartered in Amsterdam, embodies innovation and resilience, consistently reinventing itself to meet the needs of an ever-evolving world. Throughout the 20th century, Philips expanded its portfolio, venturing into consumer electronics, from televisions to audio equipment, earning it household recognition around the globe. However, the brand's recent strategic pivot towards focusing primarily on health technology is a testament to its agile vision for long-term growth and sustainability. Today, Philips operates through several key segments: Diagnosis & Treatment, Connected Care, and Personal Health. The company generates the bulk of its revenues by offering sophisticated medical imaging systems, patient monitoring solutions, and consumer health products. Its diagnostic imaging tools, like MRI and CT scanners, play a crucial role in the early detection of diseases, while its patient monitoring solutions ensure continuous care both in hospitals and remotely. Meanwhile, the personal health division supplies consumers with products designed to promote well-being, such as electronic toothbrushes and personal grooming devices. Through a strong commitment to innovation and a focus on healthcare outcomes, Philips continues to carve out its niche as a pivotal player in health technology, effectively bridging the gaps between technology and wellness.